Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience

Vaccine
Beate SanderMurray Krahn

Abstract

In response to the pandemic H1N1 influenza 2009 outbreak, many jurisdictions undertook mass immunization programs that were among the largest in recent history. The objective of this study was to determine the cost-effectiveness of the mass H1N1 immunization program in Ontario, Canada's most populous province (population 13,000,000). This analysis suggests that a mass immunization program as carried out in Ontario and many other high-income health care systems in response to H1N1 2009 was effective in preventing influenza cases and health care resource use and was also highly cost-effective despite the substantial program cost.

References

Dec 7, 1994·JAMA : the Journal of the American Medical Association·T M GovaertJ A Knottnerus
Oct 28, 1999·PharmacoEconomics·N MittmannB A Liu
Mar 23, 2004·American Journal of Epidemiology·Ira M LonginiYang Yang
Mar 11, 2005·Journal of Theoretical Biology·Rajan PatelM Elizabeth Halloran
Oct 21, 2006·Vaccine·Jeffrey C KwongDouglas G Manuel
May 23, 2007·Clinical Drug Investigation·Keith ReisingerMarlene Gyldmark
Aug 14, 2008·Healthcare Quarterly·Jeff C Kwong
Oct 31, 2008·PLoS Medicine·Jeffrey C KwongDouglas G Manuel
Jun 16, 2009·Biologicals : Journal of the International Association of Biological Standardization· Who
Oct 14, 2009·JAMA : the Journal of the American Medical Association·Anand KumarUNKNOWN Canadian Critical Care Trials Group H1N1 Collaborative
Oct 14, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza InvestigatorsMarc Ziegenfuss
Oct 15, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Marija Zivkovic GojovicChris T Bauch
Dec 5, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Ashleigh R TuiteDavid N Fisman
Dec 8, 2009·Emerging Infectious Diseases·Carrie ReedLyn Finelli
Oct 15, 2010·New Solutions : a Journal of Environmental and Occupational Health Policy : NS· American Public Health Association

❮ Previous
Next ❯

Citations

Jun 11, 2011·Critical Care : the Official Journal of the Critical Care Forum·UNKNOWN ANZIC Influenza InvestigatorsIan Seppelt
Oct 20, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Donald E Low, Allison McGeer
Sep 13, 2013·Proceedings. Biological Sciences·Daihai HeDavid J D Earn
Feb 19, 2016·Human Vaccines & Immunotherapeutics·Ayman ChitJoanne M Langley
Oct 22, 2013·American Journal of Preventive Medicine·Luc de MontignyDavid L Buckeridge
Sep 14, 2010·Vaccine·Elizabeth Rolland-Harris, Martin Tepper
Jan 24, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Richard C Larson, Anna Teytelman
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mark RobertsUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Nov 22, 2014·International Journal of Technology Assessment in Health Care·Meghann GreggRon Goeree
Sep 20, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Mark RobertsUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Jan 1, 2013·Topoi : an International Review of Philosophy·Sarah Atkinson
Feb 11, 2011·Influenza and Other Respiratory Viruses·Seyed M MoghadasDavid N Fisman
Aug 14, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Klas KellerborgPieter van Baal
May 10, 2017·Cost Effectiveness and Resource Allocation : C/E·Ellen R S RaffertyCheryl L Waldner
Feb 2, 2021·Nursing Ethics·Carmen TorrieLisa Howard
Apr 27, 2021·Frontiers in Cell and Developmental Biology·Lucas Paulo Jacinto SaavedraPaulo Cezar de Freitas Mathias

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.